
121
10
Novo Nordisk: Metrics to Drive Change
Novo Nordisk, a pharmaceutical company based near Copenhagen, serves
a global population of 285 million people with diabetes, a number expected
to double by 2030. According to the American Diabetes Association, in
the United States, over 25 million people (8.3% of the population) have
diabetes. e Centers for Disease Control reports that 1.9 million people
were diagnosed with diabetes in the United States in 2010. By 2030, the
number of diabetes patients worldwide is projected to exceed 400 million
people. Diabetes is a chronic illness, and treatment options help patients
control their blood sugar